CAS: 88637-37-0; 2-Benzhydryloxy-N,N-Dimethylethanamine,2-Hydroxypropane-1,2,3-Tricarboxylic Acid

该化合物是一种二苯水胺盐形式,是一种常用于缓解过敏,干热和普通寒冷症状的抗口炎,以镇静剂特性著称,经常用于场外睡眠辅助器;二苯水胺柠檬酸的化学结构包括一种二苯水胺分子,结合柠檬酸,增加其溶解性和稳定性;该化合物一般是白到白的结晶粉,在水中溶解,适合各种配方,包括口服和注射形式;二苯水胺主要作为H1类抗药受体的对抗剂,从而减少其体内的抗药性,从而减轻其症状,如咳嗽,流鼻鼻和喷水;此外,由于镇静剂的作用,有时被用于治疗烟雾.不过,二苯水胺与其他中系统抑制剂结合使用时,可产生副作用,如吸水,口干口和眩晕,告诫人们谨慎.

结构式图片

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-10005720-B2
    优先权日:2013-04-05
    标题:Compounds useful for the treatment of metabolic disorders and synthesis of the same
    发明人:SEXTON JONATHAN Z; BRENMAN JAY E; MUSSO DAVID L
    权利人:NORTH CAROLINA CENTRAL UNIV; UNIV NORTH CAROLINA CHAPEL HILL
    摘要:The present invention provides compounds of Formula (I): wherein variables X, Y, Z and R1 are as described herein. Some of the compounds described herein are glutamate dehydrogenase activators. The invention is also directed to pharmaceutical compositions comprising these compounds, uses of these compounds and compositions in the treatment of metabolic disorders as well as synthesis of the compounds.

    专利号:US-2023037284-A9
    优先权日:2018-11-30
    标题:Combination therapy of peptidomimetic macrocycles
    发明人:GUERLAVAIS VINCENT; ANNIS DAVID ALLEN
    权利人:AILERON THERAPEUTICS INC
    摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

    专利号:US-9365532-B1
    优先权日:2011-02-14
    标题:Synthesis, composition and use of novel therapeutic and cosmetic Schiff base products formed by reaction of a carbonyl containing moeity with a transimination nucleophilic catalyst and the use of transimination nucleophilic catalysts to increase the rate at which carbonyl containing therapeutic and cosmetic actives form Schiff base products with biological amines
    发明人:ISAACMAN STEVEN
    权利人:ISAACMAN STEVEN; NANOMETICS LLC
    摘要:The present invention relates to the synthesis, composition and use of novel moieties formed by reacting a transimination nucleophilic catalyst, molecular or polymeric, with carbonyl-containing therapeutic or cosmetic moieties. The resultant Schiff base product is highly reactive towards transimination with a biological amine. The catalyst and carbonyl-containing moiety can be molecular or polymeric, and the resultant chemical and physical properties of the Schiff base products can be engineered by appropriate selection of said catalyst. The present invention also relates to the synthesis, composition and use of novel moieties that are used as actives in sunless tanning preparations. The present invention also relates to the use of transimination nucleophilic catalysts to increase the rate at which a carbonyl-containing moiety reacts with a biological amine. The present invention also relates to the use of transimination nucleophilic catalysts to increase the rate and efficacy of commercial sunless tanning preparations. Improvements on stability and efficacy of said preparations are disclosed. While the invention has been described in terms of its preferred embodiments, those skilled in the art will recognize that the invention can be practiced with modification within the spirit and scope of the appended claims. Accordingly, the present invention should not be limited to the embodiments as described above, but should further include all modifications and equivalents thereof within the spirit and scope of the description provided herein.

    专利号:US-2019031650-A1
    优先权日:2016-01-29
    标 题 :Dna alkylation and cross-linking agents as compounds and payloads for targeted therapies
    发明人:HERZON SETH; HEALY ALAN; CRAWFORD JASON; VIZCAINO MARIA; NIKOLAYEVSKIY HERMAN
    权利人:UNIV YALE
    摘要:The present invention is directed to compounds related to precolibactin pharmaceutical compositions based upon these compounds and methods of synthesis which are employed to provide intermediates and final compounds, which are principally alkylating agents and anticancer compounds. The chemical synthetic approach disclosed facilitates the synthesis of numerous precolibactin analogs which can be used in the treatment of cancer.

    专利号:US-11458114-B2
    优先权日:2020-05-19
    标 题:Methods and compositions for enhancing synthesis secretion and transport of collagen to increase wound strength
    发明人:MARTIN ALAIN
    权利人:MARTIN ALAIN; NORTH CELL PHARMACEUTICALS INC
    摘要:A method for, and medicinal composition for, treatment of mammalian cells for enhancing synthesis, secretion and transport of collagen to increase wound strength, that includes magnesium pyruvate; calcium pyruvate; L proline; citrulline: and a liquid carrier.

    专利号:US-5922335-A
    优先权日:1995-05-15
    标 题:Uses for ascorbyl-phosphoryl-cholesterol in topical compositions
    发明人:PTCHELINTSEV DMITRI
    权利人:AVON PROD INC
    摘要:Novel uses of 3'-(L-ascorbyl-2-o-phosphoryl)-cholesterol, 3'-(L-ascorbyl-3-o-phosphoryl)-cholesterol, structural or functional isomers thereof and salts thereof (referred to collectively as 'APC compounds') are disclosed. Such novel uses include a method of reducing epidermal synthesis of abnormal elastin, especially epidermal synthesis of abnormal elastin that results from exposure to UV radiation. Also disclosed is a novel method of stimulating keratinocyte formation of triglycerides. In addition, a novel method of achieving antioxidant activity, both in the skin and also in topical compositions, is disclosed.
    杭州鼎燕化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.dingyanchem.com
    企业联系电话:18267553885👤
    📞杭州鼎燕化工有限公司 ⚠️参考联系方式
    联系人:林女士
    电话:18267553885
    手机:18267553885
    传真:0571-87156470
    邮箱:sales@dingyanchem.com
    通信地址: 杭州市江干区下沙19号大街571号下沙电子商务园4A601-602室
    邮编: 310018
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:杭州市江干区下沙19号大街571号下沙电子商务园4A601-602室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Varma A, Ford L, Patel N, Vale JA. Elimination half-life of diphenhydramine in overdose. Clin Toxicol (Phila). 2017 Jul;55(6):615-616. doi: 10.1080/15563650.2017.1296153. Epub 2017 Mar 28. 58(2):99-106. doi: 10.1080/15563650.2019.1609683. Epub 2019 May 7. 76(4):489-500. doi: 10.1016/j.annemergmed.2020.05.025. Epub 2020 Jul 9. NS26(2):35-40. doi: 10.1016/s0095-9561(16)38634-0. 24(165):270. 24(2):168-175. 49(4):281-6. doi: 10.1093/chrsci/49.4.281. 49(1):57; author reply 57. doi: 10.3109/15563650.2010.550583. 29(6):577-83. doi: 10.1007/s11096-007-9122-2. Epub 2007 May 8. 34(10):954-957. doi: 10.1177/1049909116668160. Epub 2016 Sep 13.

    合成参考文献


    参考文献:10.5664/jcsm.26405
    摘要:Ancoli-Israel S. Use of Over-the-Counter Medicine, Complementary and Alternative Medicine, and Alcohol in the Treatment of Chronic Insomnia. J Clin Sleep Med. 2005 Oct 15;1(4):e492–3. doi: 10.5664/jcsm.26405.
    参考文献:10.1007/978-3-030-51366-5_137
    摘要:Mishima K. Pharmacologic Treatment of Insomnia. 2024. In: Tasman’s Psychiatry.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知